Pharmaceuticals
Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd
* Experienced Pharmaceutical Executive * Decades of global business development, strategy and biologic drug development experience * Expertise to drive the next phase of AdAlta's growth MELBOURNE, Australia, Oct. 9, 2019 /PRNewswire/ -- The Board of AdAlta Limited (ASX:1AD), is pleased to a...
2019-10-09 09:42
1825
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy
PARIS, Oct. 9, 2019 /PRNewswire/ -- Analysis of the CANTO cohort published in
the journalAnnals of Oncology
2019-10-09 07:00
1673
Chipscreen and Novogene enter a strategic partnership for companion diagnostics development
SHENZHEN, China, Oct. 8, 2019 /PRNewswire/ -- Chipscreen Biosciences Co., Ltd. (Chipscreen, Stock Symbol: 688321.SH) and Novogene Co., Ltd. (Novogene) recently announced a strategic partnership for companion diagnostics (CDx) development. Under the agreement, Novogene will develop a CDx for Chips...
2019-10-08 20:46
3532
Drugstore Chain Mik Japan Launches International "Samurai Drugstore" Online Store with USD 100,000 Point-Back Campaign
OSAKA, Japan, Oct. 8, 2019 /PRNewswire/ -- Established 48 years ago in Japan, Mik Japan Co., Ltd. (Head office:Osaka, Japan. President: Eiji Usui), a drugstore chain managing over 50 outlets, has opened Samurai Drugstore, an international online store for drugstore products fromJapan. The company...
2019-10-08 14:00
1196
Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer
HANGZHOU, China and SHAOXING, China, Oct. 8, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Dr.Han...
2019-10-08 08:00
2414
Innovent Biologics Announces a New Placement Raised HK$2,351.33 Million
SUZHOU, China, Oct. 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announc...
2019-10-04 16:11
3401
Successful implementation of ClinSpark® at Phase I unit of a Top-10 Biopharmaceutical company
GRAFTON, Wisconsin, Oct. 2, 2019 /PRNewswire/ -- Following the successful implementation of ClinSpark® at the Phase I unit of a top-10 biopharmaceutical company inEurope, the first study database was locked where the entire trial was conducted within the system. FDA submission-ready eCRFs of all ...
2019-10-02 23:37
975
Clarivate Analytics introduces next-generation pre-clinical drug research platform with Cortellis Drug Discovery Intelligence
Updated solution enables enhanced analytics and greater utility of biology, chemistry and pharmacology data—within a single application LONDON and PHILADELPHIA, Oct. 2, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC; CCC.WS), a global leader in providing trusted insights and analytics to...
2019-10-02 01:39
8107
CapsCanada Expands Growth to New State-of-the-Art Facility
DANIA BEACH, Florida, Oct. 1, 2019 /PRNewswire/ -- CapsCanada®, the leading innovator of vegetarian K-CAPS®, accelerates growth by relocating their headquarters to a new state-of-the-art facility strategically located in Dania Beach,Florida, with close proximity to two major interstate highways, ...
2019-10-01 19:00
1173
ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability
SUZHOU, China, Sept. 30, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) released pooled safety data from the Phase Ib (GEMSTONE-101) study of the Company's anti-PD-L1 antibody CS1001 in a poster presentation at the European Society of Medical Oncology 2019 Con...
2019-09-30 18:29
2100
Ascletis Announces Departure of Chief Financial Officer
HANGZHOU and SHAOXING, China, Sept. 30, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces that Dr.Lindi Tan, Chi...
2019-09-30 16:30
2319
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis
* Idiopathic pulmonary fibrosis (IPF) is a severe and fatal disease that causes lung damage and scarring * Blocking a protein called interleukin-11 (IL11), which is abnormally high in the lungs of patients with IPF, can reverse lung fibrosis and scarring in preclinical studies * Enleofen Bi...
2019-09-30 15:00
973
Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App
HONG KONG, Sept. 30, 2019 /PRNewswire/ -- At the 21st Diabetes and Cardiovascular Risk Factors – East Meets West Symposium, Ascensia Diabetes Care has presented data from two studies, one analyzing the accuracy of blood glucose monitoring systems (BGMSs) in the low blood glucose range (LBGR) ...
2019-09-30 09:00
2392
Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China
NANJING, China and SEOUL, South Korea, Sept. 27, 2019 /PRNewswire/ -- Simcere Pharmaceutical Group and JW Pharmaceutical (KRX:001060, hereinafter called "JWP") announced a collaboration and exclusive license agreement for anti-gout drug candidate URC-102 inChina (including Chinese Hongkong & Maca...
2019-09-27 18:52
4578
New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019
Not intended for US, Canada and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 27, 2019 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced the presentation of multiple analyses from the JAVELIN clinical development program assessing BAVENCIO® (avelumab) alone or as part o...
2019-09-27 14:00
2029
New Clarivate Analytics report shows the cost to bring a drug to market has decreased to under $2B for the first time in over five years
Pharmaceutical R&D industry report provides insights into what's behind decade-high drug approval rates and reveals implications of costs and sustainability LONDON and PHILADELPHIA, Sept. 26, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC; CCC.WS), a global leader in providing trusted in...
2019-09-26 21:00
6514
Thermo Fisher Scientific Expands Clinical Trials Capabilities and Announces Collaboration with Frontier Biotechnologies Inc.
SUZHOU, China, Sept. 26, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, announced today an expansion of its integrated clinical trials supply and distribution services network, in Suzhou,China, as well as a collaboration with Frontier Biotechnologies Inc. to d...
2019-09-26 14:00
3594
OrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent
HONG KONG, Sept. 26, 2019 /PRNewswire/ -- OrbusNeich Medical K.K. of Tokyo Japan has announced that the Japan Ministry of Health, Labour, and Welfare (MHLW) has granted Shonin market approval for the COMBO Plus Coronary Stent. The COMBO Plus Coronary Stent is the first drug-eluting stent [DES] t...
2019-09-26 01:01
1559
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA's approval of the oral formulation of Akynzeo(R) in China
LUGANO, Switzerland and BEIJING, Sept. 25, 2019 /PRNewswire/ -- Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Mundipharma China Pharmaceutical, the market leader in pain management, today jointly announce that the National Medical Products Administrat...
2019-09-25 12:11
3411
Supply Chain Digitization Creates New Revenue Opportunities in the Vaccine Market
High investment in adult immunization and innovations in DNA vaccines will rejuvenate the vaccines market, finds Frost & Sullivan SANTA CLARA, California, Sept. 24, 2019 /PRNewswire/ -- The need for improved immunogenicity, delivery technologies and reliable supply are driving the shift from the...
2019-09-24 23:28
2076
Week's Top Stories
Most Reposted
Unlock the Future of Innovation: Taiwan's Premier Hardware Expo Hits the Global Stage This October
[Picked up by 314 media titles]
2024-05-24 09:41
Getac Announces World's First AI-Ready Rugged Laptop
[Picked up by 306 media titles]
2024-05-29 08:00
Ultima Markets partnered with Willis Towers Watson (WTW) to offer US$1 million in fund insurance
[Picked up by 303 media titles]
2024-05-24 12:00
Aetina Showcases Next-Gen Edge AI Solutions at COMPUTEX 2024
[Picked up by 298 media titles]
2024-05-30 15:00Inspur Cooperates with Partners to Promote the Development of Data Center Industry in Southeast Asia
[Picked up by 288 media titles]
2024-05-24 16:01Most Read
Unlock the Future of Innovation: Taiwan's Premier Hardware Expo Hits the Global Stage This October
2024-05-24 09:41
10227
Ultima Markets partnered with Willis Towers Watson (WTW) to offer US$1 million in fund insurance
2024-05-24 12:00
9042
URBAN SPORTS AND STREET ARTS MEET IN SINGAPORE AS PART OF A GLOBAL WARM-UP TO THE PARIS 2024 OLYMPIC GAMES
2024-05-24 17:11
7886
Innomix Ushers in a New Age of LBMR Immersive Experiences
2024-05-24 14:56
7823